GlobeNewsWire
03 Jul 2026, 18:22 UTC · 11w ago
Verdict
Headline takes no side. We score EMBC −1.00 across four claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Embecta reported Q2 2026 adjusted EPS of $0.27, a decline of approximately 61% sequentially and year-over-year.
More negative than 99% of claims this week
Embecta reduced its 2026 adjusted EPS guidance to $1.55 - $1.75, a roughly 43% decrease at the mid-point.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 99% of claims this week
The company reduced its dividend by 93%, lowering it to $0.01.
More negative than 98% of claims this week
Embecta is facing a securities class action lawsuit alleging it concealed competitive threats and weaknesses in its core pen needle business.
More negative than 91% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company faces a securities class action lawsuit following a disastrous earnings report, massive revenue declines, and a 93% dividend cut.
More negative than 77% of ticker scores this week
The company is mentioned as being subject to investor losses and potential legal action due to allegedly misleading financial statements.
More negative than 77% of ticker scores this week
The company is mentioned as being subject to investor losses and potential legal action due to allegedly misleading financial statements.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
7h ago
+66.9%
Price is moving against the score
$5.59 vs $3.35 close before publication (Jul 2) · not market-adjusted
EMBC chart →
